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Abstract Laminin 5, an anchoring filament protein previously 
known as niceinlkalinin/epiligrin, consists of three polypeptide 
chains, ¢~3, ~3, and ~2, encoded by the genes LAMA3, LAMB3, 
and LAMC2, respectively. The expression of laminin 5 was de- 
tected by Northern hybridization with specific cDNA probes in 
various epidermal keratinocyte cultures, whereas no expression 
of any of the three genes could be detected in foreskin fibroblast 
cultures. Transforming growth factor-l~ (TGF-I~) enhanced 
LAMA3, LAMB3, and LAMC2 gene expression in human epi- 
dermal keratinocytes, as well as in HaCaT and BalblK cells in 
culture, although the extent of enhancement was greater for 
LAMA3 and LAMC2 genes than for LAMB3. Interestingly, 
tumor necrosis factor-a, (TNF-a) alone did not alter the expres- 
sion of LAMB3 and LAMC2 genes in human epidermal ker- 
atinocytes, whereas it inhibited the expression of LAMA3. These 
results suggest hat the expression of the three genes encoding the 
laminin 5 subunits is not coordinately regulated by the cytokines 
tested. 
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1. Introduction 
Laminin 5, a member of the laminin superfamily of proteins 
comprised of at least seven isoforms, is composed of three 
polypeptide chains, ~3, f13 and ?'2, encoded by the LAMA3, 
LAMB3, and LAMC2 genes, respectively [1]. The expression 
of laminin 5, previously known as nicein/kalinin/epiligrin [24], 
is largely restricted to the basement membrane zone of the 
epidermis and other stratified squamous epithelia. Laminin 5 
is involved in the attachement of keratinocytes to the basement 
membrane within the dermal-epidermal junction [3] through 
interactions with ~z3fll and ~z6fl4 integrins [4,5], and it therefore 
facilitates epithelial-mesenchymal cohesion in vivo [6]. The ex- 
pression of the laminin 5 genes is diminished in the skin of 
patients with junctional forms of epidermolysis bullosa (JEB), 
an autosomal recessive disease characterized by blister forma- 
tion within the dermal-epidermal basement membrane of the 
skin [2,7,8], suggesting that the three genes encoding laminin 5 
*Corresponding author. Fax: (1) (215) 923 9354. 
Abbreviations: DMEM, Dulbecco's Modification of Eagle's medium; 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; KGM, ker- 
atinocyte growth medium; TGF-fl, transforming rowth factor-fl; 
TNF-c~, tumor necrosis factor-~. 
may serve as candidate genes in JEB [8]. Recently, full-length 
cDNAs for the f13 [9] and the ?'2 chains [10], and partial cDNA 
sequences for the ~3 chain [11] have been reported, and recent 
work has shown that pathogenetic mutations in the genes en- 
coding laminin 5 (LAMA3, LAMB3, and LAMC2) underlie the 
forms of JEB [12-17]. 
In attempts to identify cytokines potentially capable of 
upregulating the expression of laminin 5, we have examined the 
effects of TGF-fl  and TNF-c~ on the expression of the genes 
encoding the three subunits of laminin 5 in keratinocytes in
culture. 
2. Materials and methods 
2.1. Cell cultures 
Human epidermal keratinocytes, obtained by explanting foreskin 
specimens, were grown in serum-free, low calcium (0.15 mM), ker- 
atinocyte growth medium supplemented with epidermal growth factor, 
hydrocortisone, insulin and bovine pituitary extract (KGM, Clonetics 
Corp., San Diego, CA), and utilized in passage 1 to avoid differentia- 
tion inherent to subculturing. One hour prior to the experiments, the 
confluent keratinocyte cultures were placed in fresh KGM. 
Human dermal fibroblast cultures, established by explanting tissue 
specimens obtained from neonatal foreskin, were utilized in passages 
3 to 8. Fibroblasts were maintained in Dulbecco's Modified Eagle's 
medium (DMEM) supplemented with 10% fetal calf serum (FCS), 
2 mM glutamine and antibiotics (50 ~g/ml streptomycin, 200 U/ml 
penicillin-G, 0.25/.tg/ml Fungizone). One hour prior to the addition of 
growth factors, the confluent fibroblast cultures were rinsed with 
DMEM and placed in DMEM containing 1% FCS. 
Mouse Balb/K cells were grown in DMEM supplemented with 10% 
FCS and 5 ng/ml of murine pidermal growth factor (Clonetics Corp.). 
One hour prior to the addition of growth factors, the confluent fibro- 
blast cultures were rinsed with DMEM and placed in DMEM contain- 
ing 1% FCS. 
2.2. Cytokines/growth factors 
Human recombinant TGF-fl2 was a generous gift from Dr. David R. 
Olsen, Celtrix Laboratories, Santa Clara, CA. Throughout the text, it 
will be referred to as TGF-fl. Human recombinant TNF-c~ was pur- 
chased from Boehringer Mannheim, Indianapolis, IN. 
2.3. Northern analyses 
Cell cultures were incubated with the cytokines as indicated in the 
Results ection, and total RNA was isolated at the end of the incuba- 
tions, as previously described [18]. RNA was fractionated in 0.8% 
agarose gels containing formaldehyde, and analyzed by Northern hy- 
bridization with 32p-labeled cDNA probes [19]. The [3Zp]cDNA-mRNA 
hybrids were visualized by autoradiography, and the steady-state l vels 
of mRNA were quantitated by scanning densitometry using a He-Ne 
laser scanner at 633 nm (LKB Produkter, Bromma, Sweden). The 
following cDNAs were used: for detection of the mRNA encoding the 
c~3 chain, a 1.0 kb human cDNA was synthesized by RT-PCR of total 
human keratinocyte mRNA, using primers based on the published 
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LAMA3 se.quence [11], and subcloned into the TA vector (In¥itrogen, 
San Diego, CA); for the f13 chain, a 1 kb human cDNA fragment, 
Ka145, [9], kindly provided by Dr. R.E. Burgeson, Cutaneous Biology 
Research Center, Charlestown, MA; and for the Z2 chain, a 0.85 kb
human cDNA fragment [10], kindly provided by Dr. Karl Tryggvason, 
University of Oulu, Oulu, Finland. A rat glyceraldehyde-3-phosphate 
dehydrogenase cDNA [20] was used as a control. 
3. Results and discussion 
In order to analyze the effects of TGF-fl on the expression 
of the genes encoding laminin 5, confluent primary cultures of 
human epidermal keratinocytes were incubated with various 
concentrations (0, 0.1, 1, and 10 ng/ml) of TGF-fl, over a 24 h 
period. Total RNA was extracted and Northern analyses were 
performed using 32p-labeled cDNA probes for each of the lam- 
inin 5 chain mRNA transcripts. Autoradiograms of the hybrid- 
izations, shown in Fig. 1A, indicated that TGF-fl induces the 
expression of the three genes encoding the subunit polypeptides 
of laminin 5, LAMA3, LAMB3, and LAMC2, in a dose-de- 
pendent manner. By contrast, hybridization of the same blot 
with a glyceraldehyde-3-phosphate dehydrogenase cDNA 
(GAPDH) (Fig. 1, lower panel) indicated that the levels of the 
corresponding mRNA remained relatively unchanged upon 
TGF-fl treatment. Quantitation of the TGF-fl effect by scan- 
ning densitometry (Fig. 1B) revealed that the enhancement of 
expression of the three laminin 5 genes was not identical. Spe- 
cifically, LAMA3 gene expression was increased ~5-fold in cells 
incubated with 0.1 ng/ml of TGF-fl and up to ~ 50-fold in the 
presence of 10 ng/ml of TGF-fl. Similarly, the expression of 
LAMC2 was increased from ~3- to 40-fold under the same 
experimental conditions. In contrast, he expression of LAMB3 
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Fig. 1. Effect of TGF-fl on laminin 5 gene expression in cultured human 
epidermal keratinocytes. Confluent primary cultures of epidermal ker- 
atinocytes were incubated in s rum-free KGM without or with TGF-fl 
(0.1, 1 or 10 ng/ml). After 24 h, total RNA was isolated and analyzed 
by Northern hybridizations with cDNA probes specific for human 
LAMA3, LAMB3 and LAMC2 mRNAs. A rat glyceraldehyde-3-phos- 
phate dehydrogenase (GAPDH) c NA was used as a control (Panel 
A). The relative levels of expression of the three laminin 5 genes as 
determined byscanning densitometry of he respective autoradiograms, 
after correction for the levels of the GAPDH mRNA in the same RNA 
preparation, is indicated in panel B. 
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Fig. 2. Effect of TGF-fl and TNF-c~, alone or in combination, on 
laminin 5gene xpression i cultured epidermal keratinocytes. Conflu- 
ent keratinocyte cultures in serum-free KGM were incubated for 24 h 
in the absence or presence ofTGF-fl and/or TNF-~, in concentrations 
indicated. After 24h, total RNA was extracted and analyzed by North- 
ern hybridizations with human LAMA3, LAMB3 and LAMC2 specific 
cDNAs; a GAPDH cDNA was used as a control. 
used, and maximal stimulation was only ~ 6-fold. This variation 
in the extent of stimulation of the expression of the three lam- 
inin 5 subunit genes upon TGF-fl treatment was consistently 
observed in keratinocyte cultures established from the skin 
different donors. These data suggest that the regulation of the 
expression of the three genes encoding laminin 5 subunits i not 
tightly co-regulated. A somewhat similar phenomenon has been 
described for the regulation of the heterotrimeric type VI colla- 
gen gene expression by TGF-fl. Specifically, TGF-fl increases 
the synthesis of type VI collagen by dermal fibroblasts in cul- 
ture. This effect is accompanied byan increase in ~3(VI) colla- 
gen mRNA levels whereas the levels of ~zl(VI) and c~2(VI) 
mRNAs remain unchanged upon TGF-fl stimulation [21]. 
These data suggest that the regulation of c~3(VI) collagen gene 
expression is critical for the control of collagen type VI synthe- 
sis. 
Similar experiments were carried out utilizing mouse Balb/K 
and HACAT cells. TGF-fl enhanced the expression of LAMA3 
and LAMC2 to a greater extent han LAMB3 in HaCaT cells 
(not shown), confirming the observations made using normal 
epidermal keratinocytes (see above). A weak hybridization sig- 
nal corresponding to an mRNA of the same size as the human 
form could be detected with each cDNA probe in RNA prepa- 
rations fi'om mouse Balb/K cells (not shown). We observed 
increased expression for all three genes encoding the laminin 
5 subunits upon stimulation with TGF-fl. However, quantita- 
tion of the growth factor effect was rendered ifficult by the low 
hybridization signal, which may reflect he use of heterologous 
cDNA probes. 
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To investigate whether the laminin 5 genes were expressed 
in dermal fibroblasts, confluent cultures of these cells were 
incubated in DMEM containing 1% fetal calf serum, in the 
presence or absence of TGF-fl. RNA extraction followed by 
Northern analyses did not allow the detection of any o f  the 
three laminin 5 genes, even upon TGF-fl stimulation (not 
shown), suggesting that their expression i  the skin is restricted 
to basal keratinocytes in the epidermis. The restricted expres- 
sion of laminin 5 to basal keratinocytes contrasts that of type 
VII collagen, another component of the cutaneous basement 
membrane zone, which is expressed at a significant level also 
in dermal fibroblasts, especially upon growth factor stimulation 
[221. 
We have previously demonstrated that TNF<x, a pleiotropic 
cytokine capable of modulating the expression of a variety of 
extracellular matrix-related genes (reviewed in [23]), synergizes 
with TGF-fl to up-regulate the expression of type VII collagen, 
whereas it antagonizes the up-regulation of type i collagen gene 
expression by TGF-fl [22]. In order to examine whether the 
expression of laminin 5, and its up-regulation by TGF-fl, could 
be altered by TNF-~, cultures of primary epidermal ker- 
atinocytes were incubated for 24 hours in the presence of TGF- 
fl or TNF-a, either alone or in combination with each other. 
As shown in Fig. 2, treatment of human keratinocytes by TGF- 
fl (lanes 2 and 3, 1 and 10 ng/ml respectively) strongly elevated 
the expression of LAMA3 and LAMC2, and to a lesser extent 
that of LAMB3, confirming the data presented in Fig. 1. In 
contrast, TNF-c~ alone inhibited the expression of LAMA3, but 
not that of LAMB3 and LAMC2 (lanes 5 and 6). When TNF-~ 
was added concomitantly with TGF-fl (lane 4), it had no effect 
on the response of either gene studied to TGF-fl. 
As indicated above, junctional epidermolysis bullosa (JEB) 
is a group of blistering skin diseases and the characteristic skin 
fragility is due to reduced laminin 5 expression at the cutaneous 
basement membrane zone [7]. Low levels of laminin 5 expres- 
sion attest o the critical role of this anchoring filament protein 
in providing integrity to the dermal-epidermal junction. Thus, 
up-regulation of the genes encoding laminin 5 polypeptides 
could be expected to ameliorate the clinical manifestations in 
these patients. It should be noted, however, that the limited 
number of mutations in the three genes encoding laminin 5 
disclosed thus far are either nonsense mutations or amino acid 
substitutions [7], mutations which compromise the assembly of 
trimeric laminin 5 molecules into functional anchoring fila- 
ments. However, in case of putative regulatory mutations in 
JEB or in physiological situations requiring rapid re-epithelial- 
ization, such as in wound healing, one would anticipate that 
cytokine/growth factor-mediated up-regulation of laminin 5 
gene expression could be beneficial. 
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